FDA, IMDRF Both Back Tiered Software Regulatory System

Devices & Diagnostics Letter
A A
A federal panel is recommending that the FDA retain regulatory authority over high-risk device software, while loosening regulations around two categories considered to be lower risk.

To View This Article:

Login

Buy This Article Now

Add this article to your cart for $25.00